Back to clinical tools

BARD Score for NAFLD Fibrosis

HepatologyLiver fibrosisNAFLDBeta toolThis tool is in beta. It has undergone internal validation but still requires additional testing. Always confirm the data entered and the results obtained before clinical use. It should not be used as the sole basis for clinical decisions.
Enter BMI directly. BARD adds 1 point when BMI is >= 28 kg/m^2.
kg/m^2
Aspartate aminotransferase in U/L. The score uses the AST/ALT ratio and adds 2 points when the ratio is >= 0.8.
U/L
Alanine aminotransferase in U/L. It must be > 0 because the AST/ALT ratio is derived internally.
U/L
Diabetes mellitus presentRecord diabetes mellitus as defined in the original BARD score; this item does not distinguish type 2 diabetes.

Clinical noticeEducational tool for advanced-fibrosis risk stratification in NAFLD. Do not use the score by itself to confirm advanced fibrosis or replace specialist clinical assessment.

Context and use

BARD = 1 x I(BMI >= 28 kg/m^2) + 2 x I(AST/ALT >= 0.8) + 1 x I(diabetes mellitus present)

Total score 0-4. Published bands: 0-1 low BARD score; 2-4 high BARD score.

Certifications and Compliance

1.1.1 © 2024-2026 Medgical